Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966201413> ?p ?o ?g. }
- W1966201413 endingPage "1174" @default.
- W1966201413 startingPage "1161" @default.
- W1966201413 abstract "Bevacizumab is currently approved for the treatment of several malignancies. Haematologic toxicities are not among the main concerns associated with bevacizumab, but they have been occasionally reported. We performed a meta-analysis to determine the incidence and risk of haematologic toxicities associated with bevacizumab.Pubmed databases from 1966 to September 2010 were searched for studies reported, as well as American Society of Clinical Oncology meetings. Bevacizumab randomised clinical trials with adequate safety data profile were included. Statistical analyses were conducted to calculate the summary incidence, relative risk (RR) and 95% confidence intervals (CI).15,263 patients were included. The incidence of bevacizumab-associated all-grade and high-grade haematologic toxicities were, respectively: anaemia: 18.7% and 3.9%; neutropenia: 25.0% and 18.5%; and thrombocytopenia: 13.9% and 3.4%. Febrile neutropenia incidence was 3.8%. Compared to placebo/control arms, bevacizumab was associated with a decreased risk of all-grade (RR = 0.81; 95%CI 0.68-0.96; p = .016) and high-grade (RR = 0.73; 95%CI 0.60-0.89; p = .002) anaemia, and increased risks of all-grade (RR = 1.15; 95%CI 1.01-1.30; p = .033) and high-grade (RR = 1.08; 95%CI 1.02-1.13; p = .005) neutropenia, all-grade thrombocytopenia (RR = 1.22; 95%CI 1.00-1.48; p = .047) and febrile neutropenia (RR = 1.31; 95%CI 1.08-1.58; p = .006).Bevacizumab is associated with a lower risk of anaemia and increased risks of neutropenia, thrombocytopenia and febrile neutropenia." @default.
- W1966201413 created "2016-06-24" @default.
- W1966201413 creator A5018055906 @default.
- W1966201413 creator A5021572863 @default.
- W1966201413 creator A5052504518 @default.
- W1966201413 creator A5091352250 @default.
- W1966201413 date "2011-05-01" @default.
- W1966201413 modified "2023-10-18" @default.
- W1966201413 title "Haematologic toxicities associated with the addition of bevacizumab in cancer patients" @default.
- W1966201413 cites W1963876488 @default.
- W1966201413 cites W1964435302 @default.
- W1966201413 cites W1977379029 @default.
- W1966201413 cites W1987073370 @default.
- W1966201413 cites W1996884710 @default.
- W1966201413 cites W2025084353 @default.
- W1966201413 cites W2040379148 @default.
- W1966201413 cites W204046373 @default.
- W1966201413 cites W2046516822 @default.
- W1966201413 cites W2054154232 @default.
- W1966201413 cites W2096134439 @default.
- W1966201413 cites W2100327051 @default.
- W1966201413 cites W2100669312 @default.
- W1966201413 cites W2100785570 @default.
- W1966201413 cites W2107328434 @default.
- W1966201413 cites W2108923852 @default.
- W1966201413 cites W2114159573 @default.
- W1966201413 cites W2115005218 @default.
- W1966201413 cites W2115898240 @default.
- W1966201413 cites W2117713501 @default.
- W1966201413 cites W2122152991 @default.
- W1966201413 cites W2122298066 @default.
- W1966201413 cites W2124863710 @default.
- W1966201413 cites W2125131568 @default.
- W1966201413 cites W2125435699 @default.
- W1966201413 cites W2125923056 @default.
- W1966201413 cites W2126275851 @default.
- W1966201413 cites W2128095147 @default.
- W1966201413 cites W2132697290 @default.
- W1966201413 cites W2133450550 @default.
- W1966201413 cites W2139927762 @default.
- W1966201413 cites W2144660856 @default.
- W1966201413 cites W2145835533 @default.
- W1966201413 cites W2149347983 @default.
- W1966201413 cites W2153991063 @default.
- W1966201413 cites W2155012968 @default.
- W1966201413 cites W2156006656 @default.
- W1966201413 cites W2157769714 @default.
- W1966201413 cites W2157823046 @default.
- W1966201413 cites W2166573361 @default.
- W1966201413 cites W2167224460 @default.
- W1966201413 cites W2168865951 @default.
- W1966201413 cites W2227075123 @default.
- W1966201413 cites W2240586214 @default.
- W1966201413 cites W2246085611 @default.
- W1966201413 cites W2256786600 @default.
- W1966201413 cites W2256851415 @default.
- W1966201413 cites W2265954609 @default.
- W1966201413 cites W2468996569 @default.
- W1966201413 cites W3081058368 @default.
- W1966201413 cites W4250428608 @default.
- W1966201413 cites W4253646374 @default.
- W1966201413 doi "https://doi.org/10.1016/j.ejca.2011.03.005" @default.
- W1966201413 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21470847" @default.
- W1966201413 hasPublicationYear "2011" @default.
- W1966201413 type Work @default.
- W1966201413 sameAs 1966201413 @default.
- W1966201413 citedByCount "37" @default.
- W1966201413 countsByYear W19662014132012 @default.
- W1966201413 countsByYear W19662014132013 @default.
- W1966201413 countsByYear W19662014132014 @default.
- W1966201413 countsByYear W19662014132015 @default.
- W1966201413 countsByYear W19662014132016 @default.
- W1966201413 countsByYear W19662014132017 @default.
- W1966201413 countsByYear W19662014132018 @default.
- W1966201413 countsByYear W19662014132020 @default.
- W1966201413 countsByYear W19662014132021 @default.
- W1966201413 countsByYear W19662014132022 @default.
- W1966201413 crossrefType "journal-article" @default.
- W1966201413 hasAuthorship W1966201413A5018055906 @default.
- W1966201413 hasAuthorship W1966201413A5021572863 @default.
- W1966201413 hasAuthorship W1966201413A5052504518 @default.
- W1966201413 hasAuthorship W1966201413A5091352250 @default.
- W1966201413 hasConcept C120665830 @default.
- W1966201413 hasConcept C121332964 @default.
- W1966201413 hasConcept C126322002 @default.
- W1966201413 hasConcept C141071460 @default.
- W1966201413 hasConcept C142724271 @default.
- W1966201413 hasConcept C204787440 @default.
- W1966201413 hasConcept C27081682 @default.
- W1966201413 hasConcept C2776694085 @default.
- W1966201413 hasConcept C2777063308 @default.
- W1966201413 hasConcept C2777802072 @default.
- W1966201413 hasConcept C2778850193 @default.
- W1966201413 hasConcept C44249647 @default.
- W1966201413 hasConcept C61511704 @default.
- W1966201413 hasConcept C71924100 @default.
- W1966201413 hasConcept C82789193 @default.
- W1966201413 hasConcept C90924648 @default.